What Is KPV?

KPV is a short tripeptide composed of the amino acids lysine, proline, and valine. It is derived from α-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide known for its involvement in immune regulation and inflammatory signaling. Scientific interest in KPV stems from its ability to retain several biological properties associated with α-MSH while offering a simpler and more stable structure for laboratory investigation.

(Reference: Star et al., 1995)

How Has KPV Been Studied?

KPV has been examined in both cellular and animal research models to better understand its role in inflammatory signaling and tissue responses. Laboratory studies frequently focus on cytokine activity, cellular communication pathways, and immune-related processes.

Animal research has utilized experimental models involving intestinal inflammation, skin irritation, and tissue repair to investigate how KPV may influence inflammatory responses and epithelial barrier integrity. Researchers have also compared KPV with larger melanocortin-derived peptides to determine which biological activities remain present within the smaller tripeptide structure.

(Reference: Catania et al., 2004)

Research Observations

Published studies involving KPV have identified several recurring observations across different experimental settings.

Laboratory investigations have reported that KPV may influence cytokine signaling pathways and has been associated with reductions in certain pro-inflammatory markers within cultured cell systems. In epithelial barrier research, particularly within intestinal models, KPV has been linked to the maintenance of barrier integrity during periods of inflammatory stress.

Research also suggests that some of these biological effects may involve melanocortin receptor pathways, although additional mechanisms continue to be explored.

(Reference: Getting, 2006)

Research Applications

In laboratory environments, KPV is commonly used to investigate:

• Interactions between peptide signaling pathways and cytokine regulation.

• Experimental models focused on epithelial barrier function within the skin and gastrointestinal tract.

• Melanocortin-related signaling pathways and inflammatory response mechanisms.

• Comparative studies between α-MSH-derived peptides and smaller bioactive fragments.

(Reference: Star et al., 1995)

References

• Star, R.A., et al. (1995). Anti-inflammatory effects of α-MSH and related tripeptides. Journal of Immunology, 155(4), 1736–1743.

• Catania, A., et al. (2004). The melanocortin system in inflammation and autoimmunity. Trends in Pharmacological Sciences, 25(10), 502–507.

• Getting, S.J. (2006). Melanocortin peptides and their receptors in inflammation. Peptides, 27(2), 431–440.

All products sold by Direct Peptides are intended strictly for laboratory research use only. They are not approved for human or animal consumption, medical treatment, or therapeutic applications. The information provided on this website is for educational and informational purposes only.